Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Neoplasms | 15 | 2024 | 4353 | 0.790 |
Why?
|
Carcinoma, Hepatocellular | 10 | 2024 | 2329 | 0.690 |
Why?
|
Liver Cirrhosis | 17 | 2024 | 1959 | 0.630 |
Why?
|
Liver | 22 | 2024 | 7562 | 0.560 |
Why?
|
Elasticity Imaging Techniques | 6 | 2021 | 398 | 0.500 |
Why?
|
Cholangiocarcinoma | 3 | 2024 | 578 | 0.430 |
Why?
|
Fibroblast Growth Factors | 4 | 2024 | 871 | 0.410 |
Why?
|
Hepatitis C, Chronic | 7 | 2014 | 1032 | 0.410 |
Why?
|
Esophageal Diseases | 2 | 2004 | 166 | 0.410 |
Why?
|
Hepatitis B virus | 2 | 2016 | 530 | 0.400 |
Why?
|
Hepatic Stellate Cells | 3 | 2024 | 117 | 0.350 |
Why?
|
Cholangitis, Sclerosing | 2 | 2024 | 177 | 0.300 |
Why?
|
Choline Deficiency | 2 | 2019 | 23 | 0.280 |
Why?
|
Bile Duct Neoplasms | 2 | 2024 | 626 | 0.280 |
Why?
|
Hepatitis B | 1 | 2012 | 707 | 0.260 |
Why?
|
Yttrium Radioisotopes | 2 | 2024 | 116 | 0.250 |
Why?
|
Hepacivirus | 2 | 2012 | 1343 | 0.240 |
Why?
|
Methionine | 2 | 2019 | 569 | 0.230 |
Why?
|
Hepatitis B, Chronic | 3 | 2016 | 412 | 0.230 |
Why?
|
Common Bile Duct Diseases | 1 | 2004 | 36 | 0.230 |
Why?
|
Disease Models, Animal | 9 | 2024 | 18293 | 0.230 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2024 | 20 | 0.230 |
Why?
|
Microspheres | 2 | 2024 | 773 | 0.220 |
Why?
|
Carcinoma, Verrucous | 1 | 2003 | 27 | 0.220 |
Why?
|
Liver Transplantation | 4 | 2024 | 2412 | 0.210 |
Why?
|
Alanine Transaminase | 3 | 2012 | 607 | 0.210 |
Why?
|
Fatty Liver | 4 | 2024 | 807 | 0.210 |
Why?
|
Keratin-18 | 2 | 2015 | 37 | 0.210 |
Why?
|
Hepatitis, Alcoholic | 1 | 2024 | 109 | 0.200 |
Why?
|
Granuloma | 1 | 2004 | 327 | 0.190 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2018 | 888 | 0.180 |
Why?
|
Hepatocytes | 3 | 2024 | 1247 | 0.180 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 691 | 0.180 |
Why?
|
Cilia | 1 | 2024 | 499 | 0.170 |
Why?
|
Kupffer Cells | 2 | 2000 | 144 | 0.170 |
Why?
|
Graft Rejection | 3 | 2024 | 4499 | 0.170 |
Why?
|
Ethanol | 3 | 2024 | 1323 | 0.160 |
Why?
|
Liver Cirrhosis, Experimental | 1 | 2019 | 30 | 0.160 |
Why?
|
Cysts | 1 | 2024 | 684 | 0.160 |
Why?
|
Mice, Inbred BALB C | 3 | 2024 | 6220 | 0.160 |
Why?
|
Hepatitis, Autoimmune | 1 | 2020 | 170 | 0.150 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2020 | 222 | 0.150 |
Why?
|
Mice, Knockout | 7 | 2024 | 14448 | 0.150 |
Why?
|
Ampulla of Vater | 1 | 2018 | 150 | 0.140 |
Why?
|
Apyrase | 1 | 2020 | 373 | 0.140 |
Why?
|
Mice, Inbred C57BL | 9 | 2024 | 22332 | 0.140 |
Why?
|
Reperfusion Injury | 1 | 2024 | 1042 | 0.140 |
Why?
|
Esophagus | 1 | 2003 | 1037 | 0.140 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 1998 | 186 | 0.140 |
Why?
|
Biopsy | 10 | 2021 | 6763 | 0.130 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2016 | 13 | 0.130 |
Why?
|
Hepatitis B Core Antigens | 1 | 2016 | 90 | 0.130 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2016 | 86 | 0.130 |
Why?
|
Disease Progression | 6 | 2024 | 13632 | 0.120 |
Why?
|
Monocytes | 1 | 2024 | 2595 | 0.120 |
Why?
|
Catheterization, Central Venous | 1 | 2000 | 539 | 0.120 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2016 | 294 | 0.120 |
Why?
|
Hypertension, Portal | 2 | 2014 | 229 | 0.120 |
Why?
|
Salivary Glands, Minor | 1 | 1994 | 26 | 0.120 |
Why?
|
Carcinoma | 2 | 1998 | 2312 | 0.120 |
Why?
|
Adenocarcinoma | 4 | 2012 | 6364 | 0.120 |
Why?
|
Forefoot, Human | 1 | 1994 | 31 | 0.120 |
Why?
|
Ischemia | 1 | 2003 | 1909 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1140 | 0.110 |
Why?
|
Ethiodized Oil | 1 | 1993 | 27 | 0.110 |
Why?
|
Th17 Cells | 1 | 2020 | 786 | 0.110 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 1993 | 57 | 0.110 |
Why?
|
Histocytochemistry | 1 | 2014 | 696 | 0.110 |
Why?
|
Fats | 1 | 2014 | 99 | 0.110 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3111 | 0.110 |
Why?
|
Foot Diseases | 1 | 1994 | 147 | 0.100 |
Why?
|
Chemoembolization, Therapeutic | 1 | 1993 | 129 | 0.100 |
Why?
|
Isoantibodies | 1 | 2016 | 681 | 0.100 |
Why?
|
Hyaluronic Acid | 3 | 2010 | 484 | 0.100 |
Why?
|
Phosphatidate Phosphatase | 1 | 2011 | 21 | 0.090 |
Why?
|
Hydrocephalus | 1 | 1998 | 762 | 0.090 |
Why?
|
Crohn Disease | 1 | 2004 | 2283 | 0.090 |
Why?
|
Hepatitis, Chronic | 1 | 2011 | 53 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2047 | 0.090 |
Why?
|
Doxorubicin | 2 | 1997 | 2230 | 0.090 |
Why?
|
Axilla | 1 | 1993 | 615 | 0.090 |
Why?
|
Clinical Enzyme Tests | 1 | 2010 | 114 | 0.090 |
Why?
|
Salivary Gland Neoplasms | 1 | 1994 | 305 | 0.090 |
Why?
|
Esophagogastric Junction | 1 | 2012 | 351 | 0.090 |
Why?
|
Epinephrine | 1 | 1993 | 783 | 0.090 |
Why?
|
Cell Proliferation | 3 | 2022 | 10429 | 0.080 |
Why?
|
Lipogenesis | 1 | 2011 | 217 | 0.080 |
Why?
|
Male | 37 | 2024 | 363698 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 1998 | 1252 | 0.080 |
Why?
|
Leiomyoma | 1 | 1994 | 643 | 0.080 |
Why?
|
Endothelium, Vascular | 2 | 2004 | 4427 | 0.080 |
Why?
|
Humans | 49 | 2024 | 765968 | 0.080 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 415 | 0.080 |
Why?
|
ROC Curve | 5 | 2016 | 3620 | 0.080 |
Why?
|
Endosonography | 1 | 2012 | 626 | 0.080 |
Why?
|
Middle Aged | 27 | 2024 | 223009 | 0.070 |
Why?
|
Mice | 14 | 2024 | 81819 | 0.070 |
Why?
|
Animals | 19 | 2024 | 168764 | 0.070 |
Why?
|
Predictive Value of Tests | 7 | 2018 | 15398 | 0.070 |
Why?
|
Triiodothyronine | 1 | 2009 | 496 | 0.070 |
Why?
|
Biopsy, Needle | 3 | 2006 | 1628 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 3046 | 0.070 |
Why?
|
Diagnosis, Differential | 6 | 2006 | 12976 | 0.070 |
Why?
|
Bile Ducts | 2 | 2006 | 288 | 0.070 |
Why?
|
Fatty Acids | 1 | 2014 | 1806 | 0.070 |
Why?
|
Female | 30 | 2024 | 396112 | 0.070 |
Why?
|
Thrombosis | 1 | 2000 | 2949 | 0.060 |
Why?
|
Liver Diseases | 2 | 2024 | 1303 | 0.060 |
Why?
|
Lymphatic Metastasis | 1 | 1993 | 2887 | 0.060 |
Why?
|
Palliative Care | 2 | 1998 | 3645 | 0.060 |
Why?
|
Obesity | 4 | 2021 | 13076 | 0.060 |
Why?
|
Inflammation | 2 | 2007 | 10850 | 0.060 |
Why?
|
Soft Tissue Neoplasms | 1 | 1994 | 1165 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1995 | 0.060 |
Why?
|
Thioacetamide | 1 | 2024 | 22 | 0.060 |
Why?
|
Adult | 23 | 2024 | 223044 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2016 | 11022 | 0.060 |
Why?
|
Indenes | 1 | 2024 | 60 | 0.060 |
Why?
|
Biliary Tract | 1 | 2024 | 137 | 0.050 |
Why?
|
Furans | 1 | 2024 | 198 | 0.050 |
Why?
|
Collagen Type I | 2 | 2019 | 615 | 0.050 |
Why?
|
Lactates | 1 | 2024 | 398 | 0.050 |
Why?
|
Pyruvic Acid | 1 | 2024 | 205 | 0.050 |
Why?
|
Vacuoles | 1 | 2003 | 224 | 0.050 |
Why?
|
Rats, Inbred F344 | 1 | 2024 | 822 | 0.050 |
Why?
|
Phosphofructokinase-2 | 1 | 2022 | 33 | 0.050 |
Why?
|
Docosahexaenoic Acids | 2 | 2006 | 916 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1874 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2012 | 1661 | 0.050 |
Why?
|
Keratins | 1 | 2003 | 498 | 0.050 |
Why?
|
Lymph Nodes | 1 | 1993 | 3454 | 0.050 |
Why?
|
Pilonidal Sinus | 1 | 2001 | 17 | 0.050 |
Why?
|
Sulfones | 1 | 2024 | 447 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 2 | 2014 | 150 | 0.050 |
Why?
|
Antigens, CD1 | 1 | 2004 | 435 | 0.050 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2004 | 429 | 0.050 |
Why?
|
Condylomata Acuminata | 1 | 2001 | 79 | 0.050 |
Why?
|
Colonography, Computed Tomographic | 1 | 2003 | 170 | 0.050 |
Why?
|
Cell Size | 1 | 2003 | 625 | 0.050 |
Why?
|
Aged | 13 | 2024 | 171117 | 0.050 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2004 | 452 | 0.040 |
Why?
|
Vaginal Smears | 1 | 2003 | 513 | 0.040 |
Why?
|
DNA Transposable Elements | 1 | 2024 | 765 | 0.040 |
Why?
|
Hepatectomy | 1 | 2024 | 589 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2014 | 15880 | 0.040 |
Why?
|
Lipids | 1 | 2011 | 3315 | 0.040 |
Why?
|
Anus Neoplasms | 1 | 2004 | 336 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2004 | 1053 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 307 | 0.040 |
Why?
|
Animal Feed | 1 | 2019 | 106 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 58 | 0.040 |
Why?
|
Biphenyl Compounds | 1 | 2004 | 1019 | 0.040 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2019 | 85 | 0.040 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2000 | 190 | 0.040 |
Why?
|
Benzimidazoles | 1 | 2004 | 864 | 0.040 |
Why?
|
Catheterization | 1 | 2004 | 1425 | 0.040 |
Why?
|
Cytoplasm | 1 | 2003 | 1500 | 0.040 |
Why?
|
Vimentin | 1 | 2000 | 258 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4642 | 0.040 |
Why?
|
Phlebography | 1 | 2000 | 328 | 0.040 |
Why?
|
Lymphocytosis | 1 | 1999 | 120 | 0.040 |
Why?
|
Necrosis | 1 | 2003 | 1617 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4392 | 0.040 |
Why?
|
Tetrazoles | 1 | 2004 | 920 | 0.040 |
Why?
|
Oncogenes | 1 | 2024 | 1235 | 0.040 |
Why?
|
Aortic Diseases | 1 | 2004 | 729 | 0.040 |
Why?
|
Random Allocation | 2 | 2017 | 2395 | 0.040 |
Why?
|
HIV Seropositivity | 1 | 2004 | 961 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2006 | 1127 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 838 | 0.040 |
Why?
|
Rats | 3 | 2024 | 23707 | 0.040 |
Why?
|
Retrospective Studies | 8 | 2024 | 81514 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2000 | 438 | 0.040 |
Why?
|
Equipment Failure | 1 | 2000 | 578 | 0.040 |
Why?
|
Factor VIII | 1 | 2000 | 347 | 0.040 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2017 | 36 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2006 | 1287 | 0.030 |
Why?
|
Fibrin | 1 | 2000 | 513 | 0.030 |
Why?
|
Lactic Acid | 1 | 2022 | 1137 | 0.030 |
Why?
|
Gene Expression Regulation | 3 | 2011 | 11888 | 0.030 |
Why?
|
Aorta | 1 | 2004 | 2028 | 0.030 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14652 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2024 | 9550 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 547 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2003 | 1275 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2004 | 1811 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2006 | 1403 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2004 | 1342 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20659 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2024 | 2453 | 0.030 |
Why?
|
Colitis | 1 | 2004 | 1239 | 0.030 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2017 | 157 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2004 | 2210 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2003 | 2867 | 0.030 |
Why?
|
Sulfonamides | 1 | 2024 | 1984 | 0.030 |
Why?
|
Infusions, Subcutaneous | 1 | 2014 | 43 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 1998 | 8529 | 0.030 |
Why?
|
Fibrosis | 1 | 2021 | 2070 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20124 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1555 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 238 | 0.030 |
Why?
|
Hepatitis C | 1 | 2004 | 1597 | 0.030 |
Why?
|
Decision Trees | 1 | 2016 | 509 | 0.030 |
Why?
|
Hematoxylin | 1 | 1993 | 61 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 1993 | 70 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1997 | 679 | 0.030 |
Why?
|
DNA, Viral | 2 | 2016 | 2199 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2014 | 275 | 0.030 |
Why?
|
Emulsions | 1 | 1993 | 150 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3273 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 1999 | 9373 | 0.030 |
Why?
|
Iopamidol | 1 | 1993 | 188 | 0.030 |
Why?
|
Graft Survival | 1 | 2024 | 3890 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2000 | 969 | 0.030 |
Why?
|
Research Report | 1 | 2016 | 367 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1944 | 0.030 |
Why?
|
Radiography, Interventional | 2 | 2006 | 1129 | 0.030 |
Why?
|
Viral Core Proteins | 1 | 2012 | 158 | 0.020 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2012 | 147 | 0.020 |
Why?
|
Hepatitis | 1 | 2014 | 227 | 0.020 |
Why?
|
Bronchoscopes | 1 | 2012 | 61 | 0.020 |
Why?
|
Drug Discovery | 1 | 2020 | 1064 | 0.020 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1999 | 1376 | 0.020 |
Why?
|
Observer Variation | 1 | 2018 | 2615 | 0.020 |
Why?
|
Prospective Studies | 4 | 2021 | 54802 | 0.020 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 1994 | 263 | 0.020 |
Why?
|
Neutrophils | 1 | 2024 | 3776 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2003 | 3681 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1638 | 0.020 |
Why?
|
Age Factors | 4 | 2009 | 18380 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4137 | 0.020 |
Why?
|
Mice, Inbred ICR | 1 | 2011 | 339 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2014 | 637 | 0.020 |
Why?
|
Colorectal Neoplasms | 2 | 2003 | 6942 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2012 | 3160 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2000 | 1799 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3673 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 1998 | 21056 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1994 | 931 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2895 | 0.020 |
Why?
|
Macrophages | 1 | 2004 | 5772 | 0.020 |
Why?
|
alpha-Macroglobulins | 1 | 2009 | 60 | 0.020 |
Why?
|
Adenoma | 2 | 2003 | 2152 | 0.020 |
Why?
|
gamma-Glutamyltransferase | 1 | 2009 | 140 | 0.020 |
Why?
|
Incidence | 2 | 2000 | 21480 | 0.020 |
Why?
|
Microscopy, Video | 2 | 2000 | 241 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 40065 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3807 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2003 | 1377 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2000 | 2531 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2218 | 0.020 |
Why?
|
Esophageal and Gastric Varices | 1 | 2010 | 215 | 0.020 |
Why?
|
Apoptosis | 1 | 2024 | 9514 | 0.020 |
Why?
|
Serum | 1 | 2009 | 206 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 1608 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2009 | 355 | 0.020 |
Why?
|
Iodide Peroxidase | 1 | 2009 | 297 | 0.020 |
Why?
|
Administration, Oral | 2 | 2006 | 4015 | 0.020 |
Why?
|
Bilirubin | 1 | 2009 | 439 | 0.020 |
Why?
|
Hepatitis B e Antigens | 1 | 2007 | 135 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2012 | 1183 | 0.020 |
Why?
|
Mice, Inbred CFTR | 1 | 2006 | 18 | 0.020 |
Why?
|
Lectins | 1 | 2009 | 487 | 0.020 |
Why?
|
Mice, Congenic | 1 | 2006 | 98 | 0.020 |
Why?
|
Adipokines | 1 | 2009 | 308 | 0.020 |
Why?
|
Viral Load | 1 | 2016 | 3386 | 0.020 |
Why?
|
RNA Splicing | 1 | 2011 | 903 | 0.020 |
Why?
|
Ultrasonography | 2 | 2015 | 5993 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 2012 | 639 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2001 | 4044 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2203 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1884 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 791 | 0.020 |
Why?
|
Salivary Glands | 1 | 2006 | 231 | 0.020 |
Why?
|
Neoplasm Transplantation | 2 | 2000 | 2014 | 0.010 |
Why?
|
Arachidonic Acid | 1 | 2006 | 430 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6493 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 18973 | 0.010 |
Why?
|
Acute Disease | 2 | 2006 | 7232 | 0.010 |
Why?
|
Lung Diseases | 1 | 1994 | 1940 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2004 | 85 | 0.010 |
Why?
|
Ileum | 1 | 2006 | 558 | 0.010 |
Why?
|
Cholesterol, Dietary | 1 | 2004 | 223 | 0.010 |
Why?
|
Anus Diseases | 1 | 2004 | 53 | 0.010 |
Why?
|
Risk Assessment | 2 | 2009 | 24282 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2024 | 65188 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 2004 | 359 | 0.010 |
Why?
|
Antigens, CD1d | 1 | 2004 | 226 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2016 | 3050 | 0.010 |
Why?
|
Dextran Sulfate | 1 | 2004 | 255 | 0.010 |
Why?
|
Hemorrhage | 1 | 1994 | 3461 | 0.010 |
Why?
|
Radiography | 2 | 2009 | 6919 | 0.010 |
Why?
|
Mice, Nude | 2 | 2000 | 3618 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2001 | 5849 | 0.010 |
Why?
|
Interleukin-13 | 1 | 2004 | 388 | 0.010 |
Why?
|
Models, Immunological | 1 | 2004 | 517 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42500 | 0.010 |
Why?
|
Glycoproteins | 1 | 2009 | 2195 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2001 | 6069 | 0.010 |
Why?
|
United States | 3 | 2016 | 72903 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 2000 | 6113 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36532 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2004 | 592 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14751 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2004 | 854 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12509 | 0.010 |
Why?
|
Survival Analysis | 1 | 1993 | 10070 | 0.010 |
Why?
|
Subtraction Technique | 1 | 2003 | 512 | 0.010 |
Why?
|
Prognosis | 2 | 2011 | 29922 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1999 | 40 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5929 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1993 | 12056 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2004 | 1617 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7584 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8611 | 0.010 |
Why?
|
Pancreas | 1 | 2006 | 1700 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1999 | 325 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2006 | 39193 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 12768 | 0.010 |
Why?
|
Survival Rate | 1 | 1993 | 12795 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1333 | 0.010 |
Why?
|
Th1 Cells | 1 | 2004 | 1039 | 0.010 |
Why?
|
Exudates and Transudates | 1 | 1999 | 173 | 0.010 |
Why?
|
Homozygote | 1 | 2004 | 1775 | 0.010 |
Why?
|
Th2 Cells | 1 | 2004 | 1075 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2004 | 1250 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2003 | 872 | 0.010 |
Why?
|
Rabbits | 1 | 2004 | 4734 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2001 | 1886 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59889 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1997 | 181 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2006 | 4860 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2686 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9338 | 0.010 |
Why?
|
Tail | 1 | 1997 | 91 | 0.010 |
Why?
|
Erythrocytes | 1 | 2006 | 2395 | 0.010 |
Why?
|
Heterozygote | 1 | 2004 | 2794 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23601 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1999 | 648 | 0.010 |
Why?
|
Mutation | 2 | 2016 | 30198 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5743 | 0.010 |
Why?
|
Hepatic Artery | 1 | 1997 | 231 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4958 | 0.010 |
Why?
|
Child | 1 | 2024 | 80564 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 88835 | 0.010 |
Why?
|
Colon | 1 | 2004 | 1795 | 0.010 |
Why?
|
Cholesterol | 1 | 2004 | 2898 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2009 | 3985 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10603 | 0.010 |
Why?
|
HIV Infections | 1 | 2001 | 17533 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2009 | 12240 | 0.010 |
Why?
|
Portal Vein | 1 | 1997 | 435 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 17075 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 1999 | 1144 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1998 | 13451 | 0.010 |
Why?
|
Liposomes | 1 | 1997 | 788 | 0.010 |
Why?
|
Lung | 2 | 2006 | 10033 | 0.010 |
Why?
|
Drug Carriers | 1 | 1997 | 700 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2000 | 6203 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26318 | 0.010 |
Why?
|
Body Mass Index | 1 | 2009 | 13039 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15543 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 1997 | 2627 | 0.010 |
Why?
|
Contrast Media | 1 | 2003 | 5329 | 0.010 |
Why?
|
Transcription Factors | 1 | 2009 | 12131 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2006 | 59489 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 8102 | 0.000 |
Why?
|
Cohort Studies | 1 | 2007 | 41649 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 74840 | 0.000 |
Why?
|